Interleukin-1 alpha increases the preferential cytotoxicity of an interleukin-2-diphtheria toxin fusion protein against neoplastic lymphocytes from patients with the Sezary syndrome compared to normal lymphocytes. [electronic resource]
Producer: 19980826Description: 223-34 p. digitalISSN:- 0271-9142
- Cell Line
- Diphtheria Toxin -- pharmacology
- Drug Synergism
- Humans
- Interleukin-1 -- pharmacology
- Interleukin-2 -- pharmacology
- Lymphocytes -- drug effects
- Mycosis Fungoides -- blood
- Receptors, Interleukin-2 -- drug effects
- Recombinant Fusion Proteins -- pharmacology
- Sezary Syndrome -- blood
- T-Lymphocytes -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.